CClinicalTrials.gg
CompletedNCT05762562Updated Mar 9, 2023

Parkinson Disease Telerehabilitation Program (PDTR): a Home-motor Program. A Pilot Study.

An observational study in Parkinson Disease, sponsored by Istituti Clinici Scientifici Maugeri SpA. Completed at 1 site in Italy. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-09.

Sponsored by Istituti Clinici Scientifici Maugeri SpA · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
33
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Parkinson's disease (PD) leads to multifactorial disabilities with consequent social restrictions, especially in the COVID-19 era. Continuity of care, especially rehabilitation measures, is critical to improve or maintain an adequate QoL for patients. The Parkinson Disease Telerehabilitation Program (PDTR) is an individualized home rehabilitation program using open-source platforms (OSp).

The main purpose of this pilot study is to investigate the feasibility of TR in patients with PD by using free OS platforms (PDTR PROGRAM).

The target of this study was to have at least 90% of participants completing the program. To complete the program every single patient had to complete at least 80% of the prescribed TR sessions.

Read the detailed description

Participants were PD patient afferent to the Neurology ambulatory. Patients underwent an initial evaluation (T0) by the neurologist and physiotherapist. During T0, also the level of digital literacy was evaluated

Participants included in the study were separated into three groups based on their residual motor skills evaluated by the Short Physical Performance Battery (SPPB).

Each group corresponded to a Program (Pr). SPPB score between 12 and 10: Pr. A for patients with capable motor skills; they were were associated to the TR program A (TrP.A).

SPPB score between 9 and 7: Pr. B for patients with reduced motor skills; they were were associated to the TR program B (TrP.B).

SPPB score lower than 7: Pr. C for patients who didn't show having sufficient motor skills; they were were associated to the telemonitoring program C (TmP.C) without any exercise program.

Patients who were included in TrP.A and TrP.B underwent a TR program using OS platforms for 8 consecutive weeks.

OS platforms used are: Zoom, Skype, Google Teams, WhatsApp. The patient was given the opportunity to choose the operating system to use based on their knowledge, computer skills and ease of use to facilitate the management of the session.

Patients in TrP.A and TrP.B had to perform at home a tailored exercise program 4 times/week for 45-60 minutes.

Twice a week, the activity was performed with physiotherapist through OSp. A specific exercise program for the parkinsonian patients was structured in relation to the individual residual motor skills based on the FITT - frequency/intensity/type/time - protocol. Both programs, A and B, include multiple exercise: aerobic activities, mobility and stretching exercises for upper and lower limbs, global muscle strengthening, balance \& motor coordination training, start and stop exercises and walking training.

The exercises in program A were more complex and showed a higher intensity, while those in program B were simpler, safer and at lower intensity.

Subjects included in TmP.C participated in an 8-weeks program. A video-call was scheduled once a week to monitor the patient's clinical condition without any exercise program.

The target of this study was to have at least 90% of participants completing the program. To complete the program every single patient had to complete at least 80% of the prescribed TR sessions.

02

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • Parkinson's Disease
  • Telerehabilitation
  • Remote Physical Activity
  • Rehabilitation
  • Digital Health
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 33 is below the median of 96 across 1,057 observational studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Istituti Clinici Scientifici Maugeri SpA is the lead sponsor of 113 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Parkinson's disease patients with different residual motor skills.

Inclusion criteria

  • Hoehn \& Yahr (H\&Y) score between 1 and 3;
  • being on drug treatment stabilized with L-Dopa or dopamine agonists;
  • being able to walk independently (with or without help)
  • having adequate computer knowledge, be able to use online communication platforms and to undertake a continuous 8-weeks program.

Exclusion criteria

Exclusion Criteria:

  • Montreal Cognitive Assessment screening test score below 17.54
  • having unpredictable motor fluctuations or non-pharmacologically controlled dyskinesias
  • having neurological pathologies superimposed on PD; or cognitive, sensory, psychiatric alterations such as to make it impossible to understand and execute the exercises; or musculoskeletal and cardiopulmonary diseases that compromise mild physical activity.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
33 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Telerehabilitation with OS platforms

    Patients with Parkinson's Disease were divided into three subgruops based on their residual motor skills.

    Other: Telerehabilitation with open source platforms

Interventions

  • OtherTelerehabilitation with open source platforms

    Telerehabilitation with opensource platforms. Patients enrolled were dived into three groups based on their score in SPPB. Each group corresponded to a Program (Pr): • Pr. A is for patients with capable motor skills, Pr. B is for patients with reduced motor skills, • Pr. C is for patients who didn't show having sufficient motor skills to support a TR program. Patients who were included in TrP.A and TrP.B underwent a TR program using OS platforms for 8 consecutive weeks. A specific exercise program for the parkinsonian patients was structured in relation to the individual residual motor skills based on the FITT - frequency/intensity/type/time - protocol. Twice a week, the activity was performed with the support of a physiotherapist through OS TR platform. Subjects included in TmP.C participated in an 8-weeks program. A video-call was scheduled once a week to monitor the patient's clinical condition without any exercise program.

06

What researchers measure

Primary outcomes

  1. The opportunity of the usage TR in PD patients by using free open-source platforms

    90% of participants completing the program. To complete the program every single patient had to complete at least 80% of the prescribed TR sessions

    Time frame: 1 year

Secondary outcomes

  1. Patient's satisfaction

    Administration of a specific questionnaire to evaluate the patient's satisfaction with TR treatment program with free open-source platforms

    Time frame: 1 year

  2. Patient's agreement

    Administration of a specific questionnaire to evaluate the patient's agreement with TR treatment program with free open-source systems

    Time frame: 1 year

  3. Maintenance of clinical outcomes - Walking speed

    Walking speed using 10 Meter Walking Test (10 MWT) rated in seconds. Comparison between T0 and T1 in the groups A and B. A descriptive analysis of the results was then conducted.

    Time frame: 1 year

  4. Maintenance of clinical outcomes - Balance

    Balance using MiniBEST Test (values: 0 minimum - 28 maximum). Comparison between T0 and T1 in the groups A and B. A descriptive analysis of the results was then conducted.

    Time frame: 1 year

  5. Maintenance of clinical outcomes - Risk of falling

    Risk of falling using the Time Up and Go (TUG Test) rated in seconds. Comparison between T0 and T1 in the groups A and B. A descriptive analysis of the results was then conducted.

    Time frame: 1 year

  6. Perceived level of quality of life

    Evaluation of the level of perceived quality of life using the the Parkinson's Disease Questionnaire (short version)(PDQ-8), (values: 0 minimum - 32 maximum. The summed scor is then divided by total possible score an given as a percentage score out of 100). Comparison between T0 and T1 in the groups A and B.

    Time frame: 1 years

07

Study locations

1 site
  • Ics Maugeri
    Pavia, PV 27100, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05762562
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
Responsible party
Chiara Vellata (Physiotherapy, Istituti Clinici Scientifici Maugeri SpA) — Principal investigator
First posted
Mar 9, 2023
Start date
Feb 1, 2021
Primary completion
Feb 28, 2022
Completion
Feb 28, 2022
Last update
Mar 9, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion